MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

AtriCure Company Profile (NASDAQ:ATRC)

Consensus Ratings for AtriCure (NASDAQ:ATRC) (?)
Ratings Breakdown: 8 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $25.86 (78.82% upside)

Analysts' Ratings History for AtriCure (NASDAQ:ATRC)
Show:
DateFirmActionRatingPrice TargetActions
4/30/2016Needham & Company LLCReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/29/2016Northland SecuritiesInitiated CoverageOutperform$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/1/2016BTIG ResearchReiterated RatingBuy$28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2016Piper JaffrayReiterated RatingOutperform$25.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2016Canaccord GenuityReiterated RatingBuy$28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2015Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2015Stifel NicolausBoost Price TargetBuy$25.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/28/2015Dougherty & CoBoost Price TargetBuy$25.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/27/2014 forward)
Earnings History for AtriCure (NASDAQ:ATRC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/26/2016        
4/28/2016Q116($0.32)($0.31)$36.08 million$35.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2016Q415($0.36)($0.36)$35.90 million$35.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2015Q315($0.22)($0.22)$31.32 million$31.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2015Q215($0.21)($0.18)$30.51 million$32.58 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2015Q115($0.21)($0.19)$28.65 million$29.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2015Q414($0.20)($0.20)$28.40 million$29.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q314($0.17)($0.02)$25.60 million$26.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2014Q214($0.19)($0.10)$25.03 million$26.51 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/24/2014Q114($0.22)($0.31)$23.36 million$24.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/27/2014Q413($0.14)($0.24)$21.16 million$21.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2013Q313($0.15)($0.13)$18.30 million$20.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2013Q2 2013($0.10)($0.09)$19.42 million$20.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2013Q1 2013($0.09)($0.10)$18.63 million$19.43 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/28/2013Q4 2012($0.09)($0.12)$18.46 million$18.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2012Q312($0.11)($0.16)$17.29 million$16.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2012($0.07)($0.08)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2012($0.13)($0.10)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2011($0.07)($0.07)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2011($0.01)($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for AtriCure (NASDAQ:ATRC)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.33)($0.27)($0.30)
Q2 20162($0.31)($0.29)($0.30)
Q3 20162($0.32)($0.30)($0.31)
Q4 20162($0.34)($0.28)($0.31)
Q1 20171($0.25)($0.25)($0.25)
Q2 20171($0.26)($0.26)($0.26)
Q3 20171($0.21)($0.21)($0.21)
Q4 20171($0.20)($0.20)($0.20)
(Data provided by Zacks Investment Research)
Dividend History for AtriCure (NASDAQ:ATRC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for AtriCure (NASDAQ:ATRC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
3/8/2016Elizabeth D KrellDirectorSell10,000$16.91$169,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2015Douglas J. SeithCOOSell5,000$21.55$107,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2015Elizabeth D. KrellDirectorSell10,000$21.88$218,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2015Elizabeth D. KrellDirectorSell10,000$20.68$206,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2015Michael D HoovenDirectorSell142,268$20.81$2,960,597.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/31/2015Michael D HoovenDirectorSell20,000$20.51$410,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/30/2015Michael D HoovenDirectorSell85,000$21.01$1,785,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/13/2015Karen P RobardsDirectorSell3,150$19.53$61,519.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/5/2015Douglas J SeithCOOSell36,688$17.51$642,406.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Elizabeth D KrellDirectorSell10,000$17.63$176,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2014Douglas SeithSVPBuy1,000$15.04$15,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/13/2013Richard JohnstonInsiderSell77,610$10.00$776,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2013Douglas SeithSVPBuy10,000$9.58$95,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2013Richard JohnstonInsiderSell20,047$10.00$200,470.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/11/2013Richard M JohnstonInsiderSell2,343$10.00$23,430.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2013Richard M JohnstonInsiderSell29,348$8.96$262,958.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/18/2013Richard M JohnstonInsiderSell39,682$9.18$364,280.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/14/2013Richard M JohnstonInsiderSell95,598$8.97$857,514.06View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2013Richard M JohnstonInsiderSell35,372$9.01$318,701.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/6/2013James L LuckyVPSell50,065$8.14$407,529.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/14/2012Mark R LanningDirectorBuy11,006$7.64$84,085.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/13/2012Michael D HoovenDirectorBuy1,110$7.37$8,180.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/12/2012Michael D HoovenDirectorBuy1,150$7.10$8,165.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2012Michael D HoovenDirectorBuy1,145$7.18$8,221.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2012Michael D HoovenDirectorBuy1,215$7.15$8,687.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/7/2012Michael D HoovenDirectorBuy1,215$6.88$8,359.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/23/2012Karen P RobardsDirectorBuy1,000$6.70$6,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/16/2012Karen P RobardsDirectorBuy1,000$6.98$6,980.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for AtriCure (NASDAQ:ATRC)
DateHeadline
06/22/16 02:39 PMAtriCure : Announces the First Patient Enrolled in the FROST Cryoanalgesia Study
06/21/16 07:00 AMAtriCure Announces the First Patient Enrolled in the FROST Cryoanalgesia Study - [Business Wire] - AtriCure, Inc. , a leading innovator in surgical treatments for atrial fibrillation and left atrial appendage management, today announced the first patient has been enrolled in the FROST study at William Beaumont Hospital, Dearborn, MI.
06/20/16 07:15 AMAtriCure, Inc. breached its 50 day moving average in a Bearish Manner : ATRC-US : June 20, 2016 -
06/17/16 12:16 PMBRIEF-AtriCure files for mixed shelf offering of up to $150 mln - * Atricure Inc files for secondary stock shelf offering of up to $115.2 million
06/15/16 05:25 AMSeveral Ohio companies named to ‘Most Trustworthy’ list -
06/09/16 12:39 PMAtriCure, Inc. – Value Analysis (NASDAQ:ATRC) : June 9, 2016 -
06/08/16 07:10 AMAtriCure, Inc. breached its 50 day moving average in a Bullish Manner : ATRC-US : June 8, 2016 -
05/27/16 01:34 PMATRICURE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Secu -
05/26/16 08:50 AMEarnings Review and Stock Rundown for AtriCure, Inc. (NASDAQ:ATRC) - Wall Street Hints and News - Earnings Review and Stock Rundown for AtriCure, Inc. (NASDAQ:ATRC)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting AtriCure, Inc. (NASDAQ:ATRC) to post ...and more »
05/24/16 05:37 PMAtriCure, Inc. (NASDAQ:ATRC) Impact Score At 50 - Investor Newswire - AtriCure, Inc. (NASDAQ:ATRC) Impact Score At 50Investor NewswireAlpha One explored various online articles released on AtriCure, Inc. (NASDAQ:ATRC), and it set a daily sentiment score of -0.355 on the company. The entity has an algorithm in place to know stock sentiment on the share after exploring the content ...and more »
05/22/16 10:06 PMAfter Last Week What Do Analysts Think Of AtriCure, Inc. (ATRC) - Share Trading News - After Last Week What Do Analysts Think Of AtriCure, Inc. (ATRC)Share Trading News02/28/2014 – AtriCure, Inc. had its “market outperform” rating reiterated by analysts at JMP Securities. They now have a USD 33 price target on the stock. The share price of AtriCure, Inc. (ATRC) was up +0.93% during the last trading session, with a ...
05/13/16 10:57 PMAtriCure Inc. (ATRC) Hits New 52-week Low During May 12 Session - Equities.com - AtriCure Inc. (ATRC) Hits New 52-week Low During May 12 SessionEquities.comAtriCure Inc. (ATRC) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $14.20, AtriCure Inc. dropped to $13.44 for a new 52-week low. By the closing bell, the company's stock was at $13.78 a share ...
05/10/16 05:48 PMConsensus Rating Review for AtriCure, Inc. (NASDAQ:ATRC) - B.O.D.Y Confidential - Consensus Rating Review for AtriCure, Inc. (NASDAQ:ATRC)B.O.D.Y ConfidentialEquity research analysts currently have a consensus rating of 1 on shares of AtriCure, Inc. (NASDAQ:ATRC). Sell-side analysts will typically rate a company's stock based on extensive research. These ratings usually translate into a Buy, Sell, or Hold ...and more »
05/06/16 05:47 PMAtriCure Becomes Oversold (ATRC) - A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of AtriCure Inc (ATRC) entered into oversold territory, hitting an RSI reading of 28.8, after changing hands as low as $13.89 per share. By comparison ...
05/06/16 12:04 PMATRICURE, INC. Financials -
05/05/16 11:16 PMAtriCure Inc. (ATRC) Hits New 52-week Low During May 04 Session - Equities.com - AtriCure Inc. (ATRC) Hits New 52-week Low During May 04 SessionEquities.comAtriCure Inc. (ATRC) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $14.50, AtriCure Inc. dropped to $14.23 for a new 52-week low. By the closing bell, the company's stock was at $14.38 a share ...and more »
05/04/16 10:55 PMAtriCure Inc. (ATRC) Hits New 52-week Low During May 03 Session - Equities.com - AtriCure Inc. (ATRC) Hits New 52-week Low During May 03 SessionEquities.comAtriCure Inc. (ATRC) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $14.57, AtriCure Inc. dropped to $14.50 for a new 52-week low. By the closing bell, the company's stock was at $14.51 a share ...and more »
05/04/16 12:24 PMAtriCure, Inc. :ATRC-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/03/16 11:02 PMAtriCure Inc. (ATRC) is Trading Lower on Unusual Volume for May 02 - Equities.com - AtriCure Inc. (ATRC) is Trading Lower on Unusual Volume for May 02Equities.comAtriCure Inc. (ATRC) experienced unusually high volume on May. 02, as the stock lost 6.29% to a closing price of $14.90. The stock saw 527,605 shares trade hands over the course of the day on 4,216 trades. Given that the stock's average daily volume ...
05/03/16 11:02 PMAtriCure Inc. (ATRC) Hits New 52-week Low During May 02 Session - Equities.com - AtriCure Inc. (ATRC) Hits New 52-week Low During May 02 SessionEquities.comAtriCure Inc. (ATRC) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $15.96, AtriCure Inc. dropped to $14.59 for a new 52-week low. By the closing bell, the company's stock was at $14.90 a share ...and more »
05/03/16 05:50 PMAverage Analyst Rating for AtriCure, Inc. (NASDAQ:ATRC) - B.O.D.Y Confidential - Average Analyst Rating for AtriCure, Inc. (NASDAQ:ATRC)B.O.D.Y ConfidentialWall Street analysts have provided an average broker recommendation of 1 on AtriCure, Inc. (NASDAQ:ATRC) shares. The rating is determined by using the average of all analyst recommendations taken into consideration by Zacks Research.and more »
05/03/16 05:50 PMAtriCure Inc. (ATRC) Drops 6.29% on May 02 - Equities.com - AtriCure Inc. (ATRC) Drops 6.29% on May 02Equities.comAtriCure Inc. (ATRC) was one of the Russell 2000's biggest losers for Monday May 02 as the stock slid 6.29% to $14.90, a loss of $-1 per share. Starting at an opening price of $15.96 a share, the stock traded between $14.59 and $16.16 over the course ...and more »
05/03/16 12:36 PMETF’s with exposure to AtriCure, Inc. : May 3, 2016 -
05/03/16 11:10 AMAtriCure Suffers From Weak Chart, Downgrade -
05/02/16 06:08 PMStock Runners: AtriCure, Inc. (NASDAQ:ATRC), Perrigo Company plc Ordinary Shares (NYSE:PRGO), Mitsubishi UFJ ... - KC Register - Stock Runners: AtriCure, Inc. (NASDAQ:ATRC), Perrigo Company plc Ordinary Shares (NYSE:PRGO), Mitsubishi UFJ ...KC RegisterAtriCure, Inc. (NASDAQ:ATRC) announced that it has entered into an amended and restated term loan and revolving line of credit agreement with Silicon Valley Bank, providing access to a new $25 million five-year term loan, as well as renewing a $15 ...and more »
05/02/16 03:20 PMAtriCure to Present at the UBS Global Healthcare Conference - [at noodls] - MASON, Ohio--(BUSINESS WIRE)--May 2, 2016-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced that it ...
05/02/16 07:14 AMAtriCure, Inc. breached its 50 day moving average in a Bearish Manner : ATRC-US : May 2, 2016 -
04/29/16 05:54 PMShare Performance and Target Price Review AtriCure, Inc. (NASDAQ:ATRC) - B.O.D.Y Confidential - Share Performance and Target Price Review AtriCure, Inc. (NASDAQ:ATRC)B.O.D.Y ConfidentialDuring the most recent trading session, shares of AtriCure, Inc. (NASDAQ:ATRC) ended up with a move of -6.53%. Sell-side analysts have given a consensus target price of $24.63 on company shares. Target price projections may differ greatly from one ...and more »
04/29/16 02:33 PMEdited Transcript of ATRC earnings conference call or presentation 28-Apr-16 8:30pm GMT -
04/29/16 10:43 AMATRICURE, INC. Files SEC form 10-Q, Quarterly Report -
04/28/16 06:11 PMPeek Under The Hood: XHE Has 10% Upside - ... XHE's underlying holdings with notable upside to their analyst target prices are Heartware International Inc (HTWR), AtriCure Inc (ATRC), and Cerus Corp. (CERS). Although HTWR has traded at a recent price of $34.30/share, the average analyst target is ...
04/28/16 04:41 PMAtriCure reports 1Q loss -
04/28/16 03:36 PMAtriCure Reports First Quarter 2016 Financial Results - [at noodls] - Revenue of $35.9 million - up 20.3% as reported, 20.4% constant currency U.S. sales of $28.3 million - up 23.3% International sales of $7.7 million - up 10.1% as reported, 10.9% constant currency MASON, ...
04/28/16 03:36 PMAtriCure Announces $25 Million Term Loan with Silicon Valley Bank - [at noodls] - MASON, Ohio--(BUSINESS WIRE)--Apr. 28, 2016-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced that ...
04/28/16 03:30 PMAtriCure Inc Earnings Call scheduled for 4:30 pm ET today -
04/28/16 03:22 PMATRICURE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and Financial Co -
04/28/16 03:02 PM4:02 pm AtriCure amended and restated term loan and revolving line of credit agreement; provides access to a new $25 mln five-year term loan as well as renewing a $15 mln revolving line of credit -
04/28/16 06:07 AMQ1 2016 AtriCure Inc Earnings Release - After Market Close -
04/28/16 04:23 AMLatest Analyst Ratings For AtriCure, Inc. (ATRC) - Share Trading News - Latest Analyst Ratings For AtriCure, Inc. (ATRC)Share Trading NewsAtriCure, Inc. has a 50 day moving average of 16.79 and a 200 day moving average of 18.74. The stock's market capitalization is 543.75M, it has a 52-week low of 14.85 and a 52-week high of 28.15. The share price of the company (ATRC) was up +1.49%, ...Are Analysts Bearish AtriCure Inc. (NASDAQ:ATRC) After Last Week?Franklin IndependentAtriCure, Inc. (NASDAQ:ATRC) Wall Street Rating in FocusNews Tribuneall 4 news articles »
04/27/16 06:01 PMAtriCure, Inc. (NASDAQ:ATRC) Wall Street Rating in Focus - News Tribune - AtriCure, Inc. (NASDAQ:ATRC) Wall Street Rating in FocusNews TribuneZacks.com, founded by Len Zacks, a Mathematics Ph.D. from M.I.T. who discovered that earnings estimate revisions are the most powerful force impacting stock prices, track 6 equity research firms that cover shares of AtriCure, Inc. (NASDAQ:ATRC). Sell ...and more »
04/27/16 04:47 AMAtriCure receives FDA clearance for its AtriClip PRO2 Left Atrial Appendage Exclusion System - MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the AtriClip ...
04/26/16 06:10 PMFDA clears AtriCure's new LAA exclusion device - Seeking Alpha - FDA clears AtriCure's new LAA exclusion deviceSeeking AlphaAtriCure (NASDAQ:ATRC) receives 510(k) clearance for its AtriClip PRO2 Left Atrial Appendage (LAA) Exclusion System for use in minimally-invasive surgical procedures. The new device features increased functionality including an ambidextrous locking ...AtriCure Receives FDA Clearance for New AtriClip® DeviceBusiness Wire (press release)all 2 news articles »
04/26/16 06:10 PMAtriCure, Inc. (NASDAQ:ATRC) Share Rating Recap - B.O.D.Y Confidential - AtriCure, Inc. (NASDAQ:ATRC) Share Rating RecapB.O.D.Y ConfidentialShares of AtriCure, Inc. (NASDAQ:ATRC) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from financial ...
04/26/16 06:10 PMAtriCure Inc. (ATRC) is Trading Higher on Unusual Volume for April 25 - Equities.com - AtriCure Inc. (ATRC) is Trading Higher on Unusual Volume for April 25Equities.comAtriCure Inc. (ATRC) experienced unusually high volume on Apr. 25, as the stock gained 2.05% to a closing price of $16.94. The stock saw 445,643 shares trade hands over the course of the day on 3,694 trades. Given that the stock's average daily volume ...and more »
04/26/16 06:10 PMAtriCure wins FDA 510(k) for AtriClip Pro2 LAA device - AtriCure (NSDQ:ATRC) said today it won 510(k ... of a $5.75 million funding round with Musculoskeletal Transplant Foundation, OrthoFix Holdings, Inc. and Hankey Capital, LLC. Proceeds will be used primarily to fund further development and synthesis ...
04/26/16 07:16 AMAtriCure Receives FDA Clearance for New AtriClip® Device - [at noodls] - AtriClip PRO2 LAA Exclusion System features a streamlined hoopless end effector MASON, Ohio--(BUSINESS WIRE)--Apr. 26, 2016-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial ...
04/25/16 06:45 PMAtriCure, Inc. (NASDAQ:ATRC) Share Rating Recap - The Post - AtriCure, Inc. (NASDAQ:ATRC) Share Rating RecapThe PostShares of AtriCure, Inc. (NASDAQ:ATRC) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from financial ...
04/19/16 06:19 PMIllumina (ILMN): Bleak Q1 Preliminary Results Hurt Stock - Illumina currently carries a Zacks Rank #2 (Buy).Other favorably ranked stocks in the medical sector are AtriCure, Inc. (ATRC - Snapshot Report), NuVasive, Inc. (NUVA - Analyst Report) and Orthofix International N.V. (OFIX - Snapshot Report). All of these ...
04/18/16 06:14 PMAtriCure, Inc. (NASDAQ:ATRC) Analyst Rating Review - Clinton Financial - The Point ReviewAtriCure, Inc. (NASDAQ:ATRC) Analyst Rating ReviewClinton FinancialCovering analysts typically give Buy, Sell and Hold recommendations along with guidance and company earnings projections. Currently, there are 6 analysts that have provided ratings for AtriCure, Inc. (NASDAQ:ATRC). 4 have rated the stock a “Strong Buy ...AtriCure, Inc. (NASDAQ:ATRC) ABR At 1Vanguard Tribuneall 73 news articles »
04/15/16 04:59 PMWhat Falling Estimates & Price Mean for INSYS Therapeutics (INSY) -
About AtriCure

AtriCure logoAtriCure, Inc. is a medical device company providing atrial fibrillation (Afib) solutions. The Company has three primary product lines for cardiac tissue ablation and a product line for left atrial appendage exclusion. The Company's Isolator Synergy System, which includes its Isolator Synergy clamps, generator and switchbox, is used for the treatment of persistent and long-standing persistent Afib in patients who are undergoing open concomitant coronary artery bypass grafting, and valve replacement or repair. The cryoICE cryosurgery product line offers a range of both single use and reusable cryoablation devices. The AtriClip Left Atrial Appendage Exclusion System is designed to occlude the heart's left atrial appendage (LAA). Its radiofrequency (RF) ablation products are indicated for the ablation of cardiac tissue. The Company sells enabling technologies, including its Lumitip dissectors and Endoscopic Technologies, Inc.'s (Estech) line of reusable cardiac surgery instruments.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: ATRC
  • CUSIP: 04963C20
Key Metrics:
  • Previous Close: $15.12
  • 50 Day Moving Average: $14.70
  • 200 Day Moving Average: $17.15
  • P/E Ratio: N/A
  • P/E Growth: -0.61
  • Market Cap: $478.54M
  • Current Quarter EPS Consensus Estimate: $-1.19 EPS
Additional Links:
AtriCure (NASDAQ:ATRC) Chart for Monday, June, 27, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha